Abstract:OBJECTIVE:Viral myocarditis (VM) is one of the most common acquired myocardial diseases in children. However, its pathogenesis is not clear. Recent studies indicate that the cytotoxicity mediated by cytotoxic T lymphocyte (CTL) plays an important role in the development of myocardial injury involved in VM. Apoptosis mediated by Fas/FasL pathway is an essential mechanism of target cells damage by CTL. In this study, the authors investigated the regulatory effects of neutralizing anti-Fas ligand (anti-FasL) antibody on apoptosis and caspase-3 expression in experimental coxsackievirus B3 myocarditis and the role of the CTL mediated apoptosis in myocardium through Fas/FasL pathway in the development of VM.METHODS:A total of 80 BALB/c mice were used in the experiments. They were divided randomly into the following groups: normal control group (Gr1), CVB3 control group (Gr2), IgG control group (Gr3) and anti-FasL antibody therapy group (Gr4). The mice in Gr2, Gr3 and Gr4 were inoculated with 0.15 ml of TCID(50) 10(9)/ml coxsackie virus B3 (CVB3) and the mice in Gr1 with 0.15 ml of Eagle reagent. The mice in Gr3 and Gr4 were inoculated with IgG (0.1 mg/kg) and FasL antibody (0.1 mg/kg) on days 0 and days 3 after inoculation (p.i.), respectively. Eight mice in each group were sacrificed on day 10 p.i. Histopathological studies and terminal transferase-mediated dUTP-biotin nick end labeling (TUNEL) assays were used to quantify inflammation, necrosis and apoptosis in myocardium. The expression of active caspase-3 in myocardium was determined by immunohistochemistry. Caspase-3 mRNA and CVB3 mRNA were analyzed by reverse-transcription polymerase chain reaction (RT-PCR).RESULTS:(1) Caspase-3 activation and apoptosis were seen in the myocardium of mice with myocarditis. They had a significantly positive correlation with the changes of myocardial histopathologic scores (r = 0.81, P < 0.05; r = 0.73, P < 0.05). (2) The pathologic scores, average percentages of apoptotic cardiomyocytes, expression of active caspase-3 (protein and mRNA) and expression of CVB3 mRNA in myocardium of mice in Gr4, were significantly reduced compared to those in the myocardium of mice in Gr2 (P < 0.01, P < 0.01, P < 0.01, P < 0.01, and P < 0.05, respectively) and Gr3 (P < 0.01, P < 0.01, P < 0.05, P < 0.01, and P < 0.05, respectively).CONCLUSION:Myocytic apoptosis is a key mechanism responsible for myocardial damage in viral myocarditis. Anti-FasL antibody can effectively reduce expression of active caspase-3 protein and mRNA, viral replication, cardiomyocytic apoptosis and myocardial injury in the experimental CVB3 myocarditis.

CTLA4-Ig Relieves Inflammation in Murine Models of Coxsackievirus B3-induced Myocarditis.

Study on the Mechanism of CTLA4-Ig in the Treatment of Mice Viral Myocarditis

Blocking the CD40-CD40L Interaction by CD40-Ig Reduces Disease Progress in Murine Myocarditis Induced by CVB3.

Influence of Intravenous-Immunoglobulin on T Lymphocyte Subsets, NK Cell and Some Cytokines in Mice with Experimental Viral Myocarditis

Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.

Effect of the CD4+ T Lymphocyte in the Development of Viral Myocarditis in Mice

Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.

The Role of B Cells in Regulation of Th Cell Differentiation in Coxsackievirus B3-Induced Acute Myocarditis

Vγ1+γδT, Early Cardiac Infiltrated Innate Population Dominantly Producing IL-4, Protect Mice Against CVB3 Myocarditis by Modulating IFNγ+ T Response

The immune pattern and influence of CD4~+T cell subsets in CVB3-induced myocarditis

The Mechanisms Responsible for the Therapeutic Effects of Anti-Fas Ligand Antibody on Viral Myocarditis in Mice

Murine model of acute myocarditis and cerebral cortical neuron edema induced by coxsackievirus B4.

Coxsackievirus B3 Infection Induced Viral Myocarditis by Regulating the Expression Pattern of Chemokines in Cardiac Myocytes.

Direct Gene Transfer with IP-10 Mutant Ameliorates Mouse CVB3-induced Myocarditis by Blunting Th1 Immune Responses.

Study on the mechanism of anti-Fas in mice with viral myocaditis

Study on the Mechanism of Anti-Fas Antibody in Mice with Viral Myocarditis

The Role of Th 17 Cells and Regulatory T Cells in Coxsackievirus B 3-Induced Myocarditis

Effect of simvastatin on myocardial pathological changes in mice with acute viral myocarditis

Α-Galactosylceramide Protects Mice from Lethal Coxsackievirus B3 Infection and Subsequent Myocarditis.

In Vivo Delivery of Interleukin-35 Relieves Coxsackievirus-B3-induced Viral Myocarditis by Inhibiting Th17 Cells

The Protective Effect of Interfering TLR9-IRF5 Signaling Pathway on the Development of CVB3-induced Myocarditis.